Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
NASDAQ:ONCE
Delisted

Spark Therapeutics Stock Price (Quote)

$113.57
+0 (+0%)
At Close: Jan 24, 2020

Range Low Price High Price Comment
30 days $113.57 $113.57 Friday, 24th Jan 2020 ONCE stock ended at $113.57. During the day the stock fluctuated 0% from a day low at $113.57 to a day high of $113.57.
90 days $108.00 $113.90
52 weeks $40.64 $114.20

Historical Spark Therapeutics prices

Date Open High Low Close Volume
Feb 04, 2016 $28.48 $29.23 $27.27 $28.51 423 500
Feb 03, 2016 $27.81 $29.31 $24.60 $28.90 353 600
Feb 02, 2016 $28.67 $28.70 $26.10 $27.68 424 800
Feb 01, 2016 $27.84 $29.65 $26.93 $29.36 290 500
Jan 29, 2016 $25.67 $28.45 $25.15 $28.17 366 300
Jan 28, 2016 $27.93 $28.27 $25.05 $25.58 204 400
Jan 27, 2016 $30.15 $30.55 $27.30 $27.57 347 600
Jan 26, 2016 $31.29 $31.29 $29.60 $30.58 292 200
Jan 25, 2016 $30.61 $31.60 $29.72 $30.54 281 400
Jan 22, 2016 $30.50 $32.76 $30.43 $30.75 297 000
Jan 21, 2016 $31.03 $32.00 $29.81 $30.44 362 800
Jan 20, 2016 $26.96 $31.78 $26.04 $31.13 453 800
Jan 19, 2016 $30.11 $30.38 $26.95 $27.47 193 000
Jan 15, 2016 $31.29 $31.29 $28.56 $29.40 298 900
Jan 14, 2016 $30.67 $33.15 $28.29 $32.26 374 800
Jan 13, 2016 $32.65 $33.31 $30.41 $30.62 220 500
Jan 12, 2016 $30.68 $32.98 $30.52 $32.48 368 600
Jan 11, 2016 $34.29 $35.00 $29.03 $30.16 466 300
Jan 08, 2016 $34.80 $36.88 $34.29 $34.29 331 900
Jan 07, 2016 $36.49 $36.86 $32.97 $34.30 355 700
Jan 06, 2016 $39.80 $40.00 $36.93 $37.18 379 100
Jan 05, 2016 $42.14 $42.95 $40.20 $40.44 229 800
Click to get the best stock tips daily for free!

About Spark Therapeutics

Spark Therapeutics Spark Therapeutics, Inc. focuses on the development of gene therapy products for patients suffering from debilitating genetic diseases. The company develops SPK-RPE65, which is in Phase III clinical trial for the treatment of genetic blinding conditions called inherited retinal diseases caused by non sex-linked, autosomal recessive, or mutations in the RPE65 gene; and SPK-CHM that is in Phase I/II clinical trial for the treatment of choroideremia... ONCE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT